The University of Tokyo: New Corona May Have Effect on ‘Nafamostat’: Existing Treatment for Pancreatitis
Tokyo University: Research Team
On March 18, we announced that Nafamostat, an existing treatment for pancreatitis, may be effective in treating new types of coronavirus infection.
“It works to prevent the virus from entering human cells early in the infection.”
In the future, it will be administered on a trial basis to patients with new corona.
MERS: Effect confirmed
Similar effects have already been confirmed at MERS.
Another drug for pancreatitis, Camostat, has a similar composition, and a German research team has pointed out the same.
Experiments with the effects of the two drugs showed that nafamostat tends to prevent transmission of the new corona at lower concentrations.
Kyodo News
https://this.kiji.is/612845606029935713
New virus Effective against drugs such as acute pancreatitis
The University of Tokyo
A group at the University of Tokyo has announced that drugs such as acute pancreatitis may be used to treat patients infected with the new coronavirus.
As early as this month, they will actually begin administering the drug to patients and verifying the effect.
NHK News
https://www3.nhk.or.jp/news/html/20200318/k10012337631000.html?utm_int=all_side_ranking-social_002